✦ LIBER ✦

Artificial low-molecular-mass substrates of cholera toxin

✍ Scribed by R. Murray TAIT; Pamela M. NASSAU

Book ID: 115122633
Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 745 KB
Volume: 143
Category: Article
ISSN: 1432-1327
DOI: 10.1111/j.1432-1033.1984.tb08361.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular effects of cholera toxin on is

Molecular effects of cholera toxin on isotype differentiation

✍ Nils Lycke; Eva Severinson; Warren Strober 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 370 KB

Substrate Specificity of Low-Molecular M

Substrate Specificity of Low-Molecular Mass Bacterial dd -Peptidases

✍ Nemmara, Venkatesh V.; Dzhekieva, Liudmila; Subarno Sarkar, Kumar; Adediran, S. 📂 Article 📅 2011 🏛 American Chemical Society 🌐 English ⚖ 790 KB

Characterisation of cholera toxin by liq

Characterisation of cholera toxin by liquid chromatography—Electrospray mass spectrometry

✍ Ben L.M. van Baar; Albert G. Hulst; Eric R.J. Wils 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 591 KB

Bacterial protein toxins inhibiting low-

Bacterial protein toxins inhibiting low-molecular-mass GTP-binding proteins

✍ Ingo Just; Fred Hofmann; Harald Genth; Ralf Gerhard 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Guanine nucleotide regulation of the per

Guanine nucleotide regulation of the pertussis and cholera toxin substrates of rat glioma C6 BU1 cells

✍ Graeme Milligan 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 435 KB

Molecular basis for the binding polyspec

Molecular basis for the binding polyspecificity of an anti-cholera toxin peptide 3 monoclonal antibody

✍ Livia Otte; Tobias Knaute; Jens Schneider-Mergener; Achim Kramer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB

## Abstract The onset of autoimmune diseases is proposed to involve binding promiscuity of antibodies (Abs) and T‐cells, an often reported yet poorly understood phenomenon. Here, we attempt to approach two questions: first, is binding promiscuity a general feature of monoclonal antibodies (mAbs) an